Automated Online Direct mRNA Sequence Mapping Using Partial RNase T1 Digests
Open Access
- 23 March 2026
- journal article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (13) , 9934-9944
Abstract
Mass spectrometry-based approaches have emerged as powerful tools for the analysis of a wide range of critical quality attributes of mRNA medicines, including sequence identity, 5' capping efficiency, and 3' poly(A) tail length and heterogeneity. These critical quality attributes can impact the quality, safety, and efficacy of mRNA medicines. In this study, we have utilized online partial RNase T1 digests in conjunction with two-dimensional liquid chromatography mass spectrometry (2D LC-MS) for the direct sequence mapping of mRNA. Automated online partial RNase T1 digests are performed in conjunction with ion-pair reversed-phase liquid chromatography. No sample or solvent manipulation is required following online RNase digestions, demonstrating the simplicity of the method. High-resolution tandem mass spectrometry was used to identify the corresponding oligoribonucleotides and generate mRNA sequence maps. High sequence coverage (93-99%) for eGFP mRNA was obtained in <60 min based only on unique oligoribonucleotide identifications. Moreover, the online partial RNase T1 digests result in controlled, fully automated and reproducible mRNA digests, enabling high-throughput, direct mRNA sequence mapping studies. The online partial RNase digests offer significant advantages over existing methods for rapid, automated mRNA identity testing. Furthermore, precise control of the digest conditions via flow rate and temperature of the online RNase T1 digest, enables multiattribute monitoring of 5' capping efficiency, mRNA sequence mapping, and 3' poly(A) tail length and heterogeneity in a fully automated 2D LC-MS workflow.Keywords
Funding Information
- Biotechnology and Biological Sciences Research Council (BB/Y007514/1)
- Coalition for Epidemic Preparedness Innovations
This publication has 25 references indexed in Scilit:
- Characterisation and analysis of mRNA critical quality attributes using liquid chromatography based methodsJournal of Chromatography A, 2025
- Development of a Flow Through-Based Limited Digestion Approach for High-Throughput and High-Sequence Coverage Mapping of Therapeutic mRNAsAnalytical Chemistry, 2024
- Online Nucleotide Mapping of mRNAsAnalytical Chemistry, 2024
- Quantification and mapping of RNA modificationsTrAC Trends in Analytical Chemistry, 2024
- Characterization of mRNA therapeuticsMass Spectrometry Reviews, 2023
- Biopharmaceutical Critical Quality Attributes2023
- Liquid Chromatography–Mass Spectrometry-Based Qualitative Profiling of mRNA Therapeutic Reagents Using Stable Isotope-Labeled Standards Followed by the Automatic Quantitation Software AriadneAnalytical Chemistry, 2022
- Characterization and Sequence Mapping of Large RNA and mRNA Therapeutics Using Mass SpectrometryAnalytical Chemistry, 2022
- Oligonucleotide Sequence Mapping of Large Therapeutic mRNAs via Parallel Ribonuclease Digestions and LC-MS/MSAnalytical Chemistry, 2019
- Fragmentation of Escherichia coli mRNA by MazF and MqsRBiochimie, 2019